Holly Janes

发表

The Importance of Uncertainty and Opt-In v. Opt-Out: Best Practices for Decision Curve Analysis

Kathleen F. Kerr, Kathleen F Kerr, Tracey L Marsh, 2019, Medical decision making : an international journal of the Society for Medical Decision Making.

Net reclassification indices for evaluating risk prediction instruments: a critical review.

Kathleen F. Kerr, Kathleen F Kerr, Holly Janes, 2014, Epidemiology.

Overlap bias in the case‐crossover design, with application to air pollution exposures

Lianne Sheppard, Thomas Lumley, Holly Janes, 2005, Statistics in medicine.

Estimation and Comparison of Receiver Operating Characteristic Curves

Gary Longton, Holly Janes, Margaret Pepe, 2009, The Stata journal.

First things first: risk model performance metrics should reflect the clinical application

Kathleen F. Kerr, Kathleen F Kerr, Holly Janes, 2017, Statistics in medicine.

Accommodating Covariates in Receiver Operating Characteristic Analysis

Gary Longton, Holly Janes, Margaret S. Pepe, 2009 .

Statistical inference for net benefit measures in biomarker validation studies

Tracey L Marsh, Holly Janes, Margaret S Pepe, 2019, Biometrics.

Measuring the Performance of Markers for Guiding Treatment Decisions

Holly Janes, Margaret S. Pepe, M. Pepe, 2011, Annals of Internal Medicine.

Case–Crossover Analyses of Air Pollution Exposure Data: Referent Selection Strategies and Their Implications for Bias

Thomas Lumley, Lianne Sheppard, Holly Janes, 2005, Epidemiology.

Combining biomarkers to optimize patient treatment recommendations

Holly Janes, Ying Huang, H. Janes, 2014, Biometrics.

Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?

Holly Janes, Ziding Feng, Margaret S Pepe, 2016, Clinical chemistry.

Matching in Studies of Classification Accuracy: Implications for Analysis, Efficiency, and Assessment of Incremental Value

Holly Janes, Margaret S Pepe, M. Pepe, 2008, Biometrics.

Methods for Evaluating Prediction Performance of Biomarkers and Tests

Holly Janes, Margaret S. Pepe, M. Pepe, 2013 .

Immune-correlates analysis of an HIV-1 vaccine efficacy trial.

Guido Ferrari, Youyi Fong, Jaranit Kaewkungwal, 2012, The New England journal of medicine.

Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use.

Kathleen F. Kerr, Kathleen F Kerr, Holly Janes, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An Approach to Evaluating and Comparing Biomarkers for Patient Treatment Selection

Holly Janes, Margaret S Pepe, Ying Huang, 2014, The international journal of biostatistics.

Net risk reclassification p values: valid or misleading?

Holly Janes, Margaret S Pepe, M. Pepe, 2014, Journal of the National Cancer Institute.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration

John P. A. Ioannidis, Jeremy M. Grimshaw, Peter Kraft, 2011, European Journal of Human Genetics.

A Framework for Evaluating Markers Used to Select Patient Treatment

Holly Janes, Margaret S. Pepe, Ying Huang, 2014, Medical decision making : an international journal of the Society for Medical Decision Making.

Identifying target populations for screening or not screening using logic regression

Holly Janes, Charles Kooperberg, Margaret Pepe, 2005, Statistics in medicine.

Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic or Prognostic Marker

Gary Longton, Holly Janes, Margaret S. Pepe, 2004 .

The optimal ratio of cases to controls for estimating the classification accuracy of a biomarker.

Holly Janes, Margaret Pepe, 2006, Biostatistics.

Insights into latent class analysis of diagnostic test performance.

Margaret Sullivan Pepe, Holly Janes, M. Pepe, 2007, Biostatistics.

Rejoinder: Combining biomarkers to optimize patient treatment recommendations

Holly Janes, Ying Huang, H. Janes, 2014, Biometrics.

Assessing the Value of Risk Predictions by Using Risk Stratification Tables

Holly Janes, Margaret S Pepe, M. Pepe, 2008, Annals of Internal Medicine.

The Fundamental Difficulty With Evaluating the Accuracy of Biomarkers for Guiding Treatment.

Daniel J Sargent, Patrick J Heagerty, Holly Janes, 2015, Journal of the National Cancer Institute.

Adjusting for covariate effects on classification accuracy using the covariate-adjusted receiver operating characteristic curve.

Holly Janes, Margaret S Pepe, M. Pepe, 2009, Biometrika.

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Holly Janes, David C Montefiori, Peter B Gilbert, 2013, The New England journal of medicine.

Adjusting for Covariate Effects on Classification Accuracy Using the Covariate-Adjusted ROC Curve

Holly Janes, Margaret S. Pepe, 2006 .

Designing a study to evaluate the benefit of a biomarker for selecting patient treatment

Holly Janes, Margaret S Pepe, M. Pepe, 2015, Statistics in medicine.

Letter by Pepe et al regarding article, "Use and misuse of the receiver operating characteristic curve in risk prediction".

Holly Janes, Margaret S Pepe, M. Pepe, 2007, Circulation.

Assessing Treatment‐Selection Markers using a Potential Outcomes Framework

Holly Janes, Peter B Gilbert, Ying Huang, 2012, Biometrics.

Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies

Holly Janes, David C Montefiori, Peter B Gilbert, 2009, Journal of Virology.

Accommodating Covariates in ROC Analysis.

Gary Longton, Holly Janes, Margaret Pepe, 2009, The Stata journal.

MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

Tomer Hertz, Julian Wolfson, Holly Janes, 2012, PloS one.

Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

Holly Janes, Ziding Feng, Margaret S. Pepe, 2008, Journal of the National Cancer Institute.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

Donald K Carter, Holly Janes, Devan V Mehrotra, 2008, The Lancet.

Statistical analysis of air pollution panel studies: an illustration.

Lianne Sheppard, Holly Janes, L. Sheppard, 2008, Annals of epidemiology.

Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial

Raphael Gottardo, Tomer Hertz, John Sidney, 2014, Journal of Virology.

Commentary: Reporting standards are needed for evaluations of risk reclassification.

Holly Janes, Margaret S Pepe, M. Pepe, 2011, International journal of epidemiology.

Practice of Epidemiology Adjusting for Covariates in Studies of Diagnostic, Screening, or Prognostic Markers: an Old Concept in a New Setting

Holly Janes, Margaret S Pepe, M. Pepe, 2022 .